| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/11/2008 | WO2008148731A1 Pharmaceutical formulation for the production of rapidly disintegrating tablets |
| 12/11/2008 | WO2008148515A1 Intranasal administration of asenapine and pharmaceutical compositions therefor |
| 12/11/2008 | WO2008148503A1 Solid pharmaceutical formulation |
| 12/11/2008 | WO2008148484A1 Improved taste-masking extrudates |
| 12/11/2008 | WO2008148478A2 Gastroretentive system comprising an alginate body |
| 12/11/2008 | WO2008148359A1 The therapeutic uses of imidazol-5-carboxylic acid derivatives |
| 12/11/2008 | WO2008148303A1 A composition for treating vegetative dystonine syndrome and pharmaceutical preparation and application thereof |
| 12/11/2008 | WO2008148292A1 An ophthalmic, otic or nasal composition and its use |
| 12/11/2008 | WO2008148212A2 High-amylose sodium carboxymethyl starch sustained release excipient and process for preparing the same |
| 12/11/2008 | WO2008129303A3 Sustained release |
| 12/11/2008 | WO2008127456A3 Compositions for the reversal and detoxification of anesthetics and other compounds and methods of their use |
| 12/11/2008 | WO2008115961A3 Sustained-release composition |
| 12/11/2008 | WO2008112824A3 Oral zinc medicants useful for safely lowering free copper absorption and free copper levels |
| 12/11/2008 | WO2008112565A3 Method and composition for treating cancer |
| 12/11/2008 | WO2008109712A3 Nanoparticle delivery systems for membrane-integrating peptides |
| 12/11/2008 | WO2008104996A3 Water dispersible pharmaceutical formulation and process for preparing the same |
| 12/11/2008 | WO2008082321A8 Emulsion of perfluoroorganic compounds for medical use and a methods for the preparation and the use thereof |
| 12/11/2008 | WO2008076467A3 Intraoperative imaging methods |
| 12/11/2008 | WO2008074108A3 Controlled release pharmaceutical composition of anti-hyperglycemic agent and its preparation |
| 12/11/2008 | WO2008070571A3 Vesicles of self-assembling block copolymers and methods for making and using the same |
| 12/11/2008 | WO2008066965A3 Articles comprising large-surface-area bio-compatible materials and methods for making and using them |
| 12/11/2008 | WO2008062481A3 Formulations of peg-interferon alpha conjugates |
| 12/11/2008 | WO2008060574A3 Therapeutic contact lenses with anti-fungal delivery |
| 12/11/2008 | WO2008045461A3 Transdermal diethylstilbestrol for treating prostate cancer |
| 12/11/2008 | WO2008039615A3 Controlled release hydrogel formulation |
| 12/11/2008 | WO2008021875A3 Pharmaceutical tablets containing a plurality of active segments |
| 12/11/2008 | WO2008002905A3 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
| 12/11/2008 | WO2007092432A3 Liquid-filled nanodroplets for anti-cancer therapy |
| 12/11/2008 | WO2007075859A3 Systems and methods for the delivery of corticosteroids having an increased lung deposition |
| 12/11/2008 | WO2006073950B1 Nanoparticles for protein drug delivery |
| 12/11/2008 | US20080306253 Matrix made of a polysaccharide modified under an electron beam with a functional organosilicon compound |
| 12/11/2008 | US20080306247 Antibody-containing solution formulations |
| 12/11/2008 | US20080306152 Compositions containing prodrugs of florfenicol and methods of use |
| 12/11/2008 | US20080306118 Process for the crystallization of (R) - or (S) - Lansoprazole |
| 12/11/2008 | US20080306104 Tamper-resistant oral opioid agonist formulations |
| 12/11/2008 | US20080306079 External preparation for allergic diseases |
| 12/11/2008 | US20080306013 Illudin analogs useful as antitumor agents |
| 12/11/2008 | US20080305177 Method of administering testosterone |
| 12/11/2008 | US20080305176 Process For Loading Polymer Particles With Drug |
| 12/11/2008 | US20080305175 Micro-Container |
| 12/11/2008 | US20080305174 Polymeric nanocapsules for use in drug delivery |
| 12/11/2008 | US20080305173 Amorphous drug beads |
| 12/11/2008 | US20080305172 Ophthalmic depot formulations for periocular or suconjunctival administration |
| 12/11/2008 | US20080305171 Pyrrolopyrazine, formulations, methods of manufacture, and methods of use there |
| 12/11/2008 | US20080305170 Method for producing calcium component powder containing oil-soluble substance |
| 12/11/2008 | US20080305169 Pharmaceutical Compositions Comprising Nitrogen-Containing Fused Ring Coumpounds |
| 12/11/2008 | US20080305168 In-Situ Melting and Gelling Tablet Composition For Oral Care |
| 12/11/2008 | US20080305167 Tamper-resistant oral opioid agonist formulations |
| 12/11/2008 | US20080305166 Robust rapid disintegration tablet formulation |
| 12/11/2008 | US20080305165 Sustained release oral formulation and process for the preparation thereof |
| 12/11/2008 | US20080305164 Crystalline composition containing escitalopram |
| 12/11/2008 | US20080305163 Butylphthalide soft gel capsule and its preparation procedure |
| 12/11/2008 | US20080305162 Incontinence Treatment Methods |
| 12/11/2008 | US20080305161 Injectable depot formulations and methods for providing sustained release of nanoparticle compositions |
| 12/11/2008 | US20080305160 Oral Medicament For The Modified Release Of At Least One Active Principle, In Multimicrocapsule Form |
| 12/11/2008 | US20080305159 Ibuprofen-Hydrocodone-Antihistamine Composition |
| 12/11/2008 | US20080305158 Methods For the Preparation of Stable Pharmaceutical Solid Dosage Forms of Atorvastatin and Amlodipine |
| 12/11/2008 | US20080305157 Encapsulation and separation of charged organic solutes inside catanionic vesicles |
| 12/11/2008 | US20080305156 Echogenic Vehicle for Clinical Delivery of Plasminogen Activator and Other Fibrin-Binding Therapeutics to Thrombi |
| 12/11/2008 | US20080305155 Transdermal Systems Containing Multilayer Adhesive Matrices to Modify Drug Delivery |
| 12/11/2008 | US20080305153 Antibacterial Sol-Gel Coating Solution, Method for Preparing Antibacterial Sol-Gel Coating Solution, Antibacterial Articles, and Method and Equipments for Preparing Antibacterial Articles |
| 12/11/2008 | US20080305152 Methods of Inducing Melanogenesis in a Subject |
| 12/11/2008 | US20080305151 Dipeptide-Comprising Composition for Oral Administration |
| 12/11/2008 | US20080305150 Polymer Composition And Dosage Forms Comprising The Same |
| 12/11/2008 | US20080305149 Mucoadhesive vesicles for drug delivery |
| 12/11/2008 | US20080305147 Drug Delivery System For The Prevention Of Cerebral Vasospasm |
| 12/11/2008 | US20080305145 Process for demineralization of bone matrix with preservation of natural growth factors |
| 12/11/2008 | US20080305142 Cell Free Biosynthesis of High-Quality Nucleic Acid and Uses Thereof |
| 12/11/2008 | US20080305140 Long-Term Delivery Formulations and Methods of Use Thereof |
| 12/11/2008 | US20080305139 Pharmaceutical Compositions Comprising Dextran with a Molecular Weight of 1.0-100 Kda and Processes for Their Preparation |
| 12/11/2008 | US20080305133 Novel Cosmetic or Dermatological Combinations Comprising Modified Titanium Dioxide Particles |
| 12/11/2008 | US20080305132 Cosmetic Patch for Skin Treatment |
| 12/11/2008 | US20080305046 Molecular imaging methods for diagnosis and evaluation of ocular and systemic diseases |
| 12/11/2008 | US20080305038 Transport of Nano-and Macromolecular Structures Into Cytoplasm and Nucleus of Cells |
| 12/11/2008 | US20080305037 Linkers for anchoring targeting ligands |
| 12/11/2008 | DE112007000247T5 Vorrichtung zur Herstellung eines laminierten Mikrokapselblatts An apparatus for producing a laminated microcapsule sheet |
| 12/11/2008 | DE102007026550A1 Extrudate mit verbesserter Geschmacksmaskierung Extrudates with improved taste masking |
| 12/11/2008 | DE102007026037A1 Gastroretentives System mit Alginat-Körper Gastroretentive system with alginate-body |
| 12/11/2008 | DE102005015128B4 Wafer enthaltend Steroidhormone Wafer containing steroid hormones |
| 12/11/2008 | CA2697959A1 Pharmaceutical composition comprising a substrate and a coating containing an active ingredient and polyvinylalcohol |
| 12/11/2008 | CA2690151A1 Enteric coated, soluble creatine and polyethylene glycol composition for enhanced skeletal uptake of oral creatine |
| 12/11/2008 | CA2690089A1 Methods and compositions for delivery of medicaments to the lungs |
| 12/11/2008 | CA2689594A1 Film preparation with rapidly dissolving property and flexibility |
| 12/11/2008 | CA2689486A1 Extrudates with improved taste masking |
| 12/11/2008 | CA2689476A1 Intranasal carbetocin formulations and methods for the treatment of autism |
| 12/11/2008 | CA2689434A1 Tamper resistant lipid-based oral dosage form for opioid agonists |
| 12/11/2008 | CA2689313A1 High-amylose sodium carboxymethyl starch sustained release excipient and process for preparing the same |
| 12/11/2008 | CA2689271A1 Chondrocyte container and method of use |
| 12/11/2008 | CA2689242A1 Agent and method for treatment of cancer |
| 12/11/2008 | CA2689049A1 Gastroretentive system comprising an alginate body |
| 12/11/2008 | CA2688542A1 Methods and compositions for administration of oxybutynin |
| 12/11/2008 | CA2688478A1 Slow release pharmaceutical composition made of microparticles |
| 12/11/2008 | CA2688415A1 Nucleic acid nanoparticles and uses therefor |
| 12/11/2008 | CA2688389A1 Pharmaceutical formulation for the production of rapidly disintegrating tablets |
| 12/11/2008 | CA2688268A1 Formulation of meningitis vaccines |
| 12/11/2008 | CA2687246A1 High temperature stable peptide formulation |
| 12/11/2008 | CA2686964A1 Pharmaceutical formulation for the production of rapidly disintegrating tablets |
| 12/11/2008 | CA2686558A1 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same |
| 12/11/2008 | CA2600147A1 Combination for treatment of diabetes mellitus |
| 12/10/2008 | EP2000152A2 Solid preparation having improved solubility |